Free shipping on all orders over $ 500

Mycophenolic acid

Cat. No. M3416

All AbMole products are for research use only, cannot be used for human consumption.

Mycophenolic acid Structure
Synonym:

Mycophenolate, RS-61443; MPA

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
50mg USD 30 In stock
100mg USD 45 In stock
500mg USD 85 In stock
1g USD 110 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Mycophenolic acid (mycophenolate) is an immunosuppressant agent used to prevent rejection in organ transplantation. Mycophenolic acid (mycophenolate) is derived from the fungus Penicillium stoloniferum. Mycophenolate mofetil is metabolised in the liver to the active moiety mycophenolic acid. Mycophenolic acid (mycophenolate) inhibits inosine monophosphate dehydrogenase, the enzyme that controls the rate of synthesis of guanine monophosphate in the de novo pathway of purine synthesis used in the proliferation of B and T lymphocytes. Mycophenolic acid (mycophenolate) is potent and can be used in place of the older anti-proliferative azathioprine. Mycophenolic acid (mycophenolate) is usually used as part of a three-compound regimen of immunosuppressants, also including a calcineurin inhibitor (ciclosporin or tacrolimus) and prednisolone.

Chemical Information
Molecular Weight 320.34
Formula C17H20O6
CAS Number 24280-93-1
Solubility (25°C) DMSO ≥ 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Agnieszka Siebert, et al. Anticancer Properties of Amino Acid and Peptide Derivatives of Mycophenolic Acid

[2] Agnieszka Siebert, et al. New Analogues of Mycophenolic Acid

[3] A Dasgupta. Therapeutic Drug Monitoring of Mycophenolic Acid

[4] Sarah J Strathie Page, et al. Mycophenolic acid in dermatology a century after its discovery

Related Immunology/Inflammation Products
Omalizumab

Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal antibody that specifically binds to free human immunoglobulin E (IgE) and to membrane-bound form of IgE (mIgE).

Daratumumab

Daratumumab (Daratumumab) is a first-in-class, specific anti-CD38 monoclonal antibody (IgG1). (for human or immunodeficient mice).

Laquinimod

Laquinimod (ABR-215062) is a new orally active immunoregulator effectively inhibits development and relapses of experimental autoimmune encephalomyelitis.

Cyclosporine A

Cyclosporine A (CsA,Cyclosporin A) is an immunosuppressant that binds to cyclophilin and inhibits calcineurin with an IC50 of 7 nM. Cyclosporine A [CsA] binds to the cyclophilin 18 (Cyp18)-CsA complex. the Cyp18-CsA complex recruits calcium-regulated neurophosphatase (CaN), leading to the blocking of cytokine gene transcription in activated T cells. CsA is a highly specific inhibitor of T-cell activation.

Pimecrolimus

Pimecrolimus is an immunomodulating agent used in the treatment of atopic dermatitis.

  Catalog
Abmole Inhibitor Catalog




Keywords: Mycophenolic acid, Mycophenolate, RS-61443; MPA supplier, Immunology/Inflammation, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.